Aloxi
Drug
Eisai Inc.
Total Payments
$22,689
Transactions
26
Doctors
13
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $22,689 | 26 | 13 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $19,165 | 3 | 84.5% |
| Consulting Fee | $3,025 | 1 | 13.3% |
| Food and Beverage | $499.46 | 22 | 2.2% |
Payments by Type
Research
$19,165
3 transactions
General
$3,524
23 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Unique schedule of Palonosetron, Ondansetron, and Dexamethasone for the Prevention of Delayed Nausea and Vomiting in Patients Receiving Moderately Emetogenic Myeloablative Chemotherapy | Eisai Inc. | $19,165 | 0 |
Top Doctors Receiving Payments for Aloxi
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Atlanta, GA | $19,165 | 3 |
| , MD | Hospice and Palliative Medicine | La Jolla, CA | $3,025 | 1 |
| , MD | Internal Medicine | Albuquerque, NM | $89.09 | 1 |
| , MD | Medical Oncology | San Luis Obispo, CA | $67.95 | 4 |
| , MD | Hematology & Oncology | San Luis Obispo, CA | $52.05 | 3 |
| , MD | Pediatrics | Sioux Falls, SD | $50.00 | 1 |
| , MD | Hematology & Oncology | San Luis Obispo, CA | $49.64 | 3 |
| , MD | Hematology & Oncology | Fresno, CA | $39.67 | 2 |
| , M.D | Hematology & Oncology | Newport Beach, CA | $39.66 | 2 |
| , MD | Dermatology | San Luis Obispo, CA | $34.22 | 2 |
| , M.D | Medical Oncology | Santa Monica, CA | $24.35 | 1 |
| , MD | Hospitalist | Rogers, AR | $19.47 | 1 |
| , M.D | Medical Oncology | San Antonio, TX | $19.37 | 1 |
| , M.D | Hematology & Oncology | Merced, CA | $13.99 | 1 |
Ad
Manufacturing Companies
- Eisai Inc. $22,670
- Helsinn Therapeutics (U.S.), Inc. $19.37
Product Information
- Type Drug
- Total Payments $22,689
- Total Doctors 13
- Transactions 26
About Aloxi
Aloxi is a drug associated with $22,689 in payments to 13 healthcare providers, recorded across 26 transactions in the CMS Open Payments database. The primary manufacturer is Eisai Inc..
Payment data is available from 2017 to 2017. In 2017, $22,689 was paid across 26 transactions to 13 doctors.
The most common payment nature for Aloxi is "Unspecified" ($19,165, 84.5% of total).
Aloxi is associated with 1 research study, including "A Unique schedule of Palonosetron, Ondansetron, and Dexamethasone for the Prevention of Delayed Nausea and Vomiting in Patients Receiving Moderately Emetogenic Myeloablative Chemotherapy" ($19,165).